TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MYLIFE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MYLIFE

ST13

US500000086366332

Classe

9, 10, 38, 44

Pedido

86366332

Registro

6150285

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

53

Atualização mais recente

07/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

9, 10, 38, 44

Data de depósito

14/08/2014

Data de registro

15/09/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/09/2020

Última transação

07/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

BURGDORF, CH

Examinador

CRENNAN, KEVIN GERARD

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

MYLIFE DIABETES CARE AG
YPSOMED AG
TecPharma Licensing AG

Representantes

Joel D. Leviton STINSON LLP

Classificação técnica

Classes Nice

Classe 9Classe 10Classe 38Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

Media for digital transmission, storage, and processing of medical data in relation with continuous subcutaneous insulin infusion therapy and data provided by medical instruments and devices in the nature of insulin pumps, blood glucose meters, and patch pumps for continuous subcutaneous insulin infusion, namely, smart phones, smart tablets, smart watches, and smart bracelets; Software for depicting and analyzing data namely blood glucose values, blood glucose trends versus time, blood glucose target value, current bolus values, bolus history, insulin on board or unused insulin, carbohydrate values, carbohydrate factor, insulin sensitivity factor, duration of insulin action, carbohydrate to insulin factor, calculation and display of meal bolus, calculation and display of correction bolus, calculation and display of insulin stacking, display of bolus suggestion, current basal rate, basal rate profile, basal rate history provided by medical instruments and devices for continuous subcutaneous insulin infusion, namely, insulin pumps, blood glucose meters, and patch pumps; Downloadable databases featuring blood glucose values; Software for managing data pertaining to infused insulin and infused insulin history of patients using insulin pumps; Software for data management of patients using insulin pumps; Remote control devices, namely, remote controls for medical instruments and devices in the nature of insulin pumps, blood glucose meters, and patch pumps that provide continuous subcutaneous insulin infusion

Classe 10

Media for digital transmission, storage, and processing of medical data in relation with continuous subcutaneous insulin infusion therapy and of data provided by medical instruments and devices in the nature of insulin pumps, blood glucose meters, and patch pumps for continuous subcutaneous insulin infusion, namely, handheld, body-worn and implanted devices, personal diabetes managers devices, and smart medical devices in the nature of wireless handheld devices; all of the foregoing that allow users to control insulin pumps, blood glucose meters and patch pumps for medical purposes; Medical instruments and devices, namely, insulin pumps sold empty, blood glucose meters, and patch pumps sold empty, for continuous subcutaneous insulin infusion

Classe 38

Providing access to information for user of medical instruments and devices for self-medication, particularly diabetes therapies, by means of a global computer information network; providing online information forums, chatrooms, chat lines, and chat forums for the transmission of messages and information between computer users with regard to medical instruments and devices for self-medication, particularly, diabetes therapies

Classe 44

Providing online computer databases featuring blood glucose values, blood glucose trends versus time, blood glucose target value, current bolus values, bolus history, insulin on board or unused insulin, carbohydrate values, carbohydrate factor, insulin sensitivity factor, duration of insulin action, carbohydrate to insulin factor, calculation and display of meal bolus, calculation and display of correction bolus, calculation and display of insulin stacking, display of bolus suggestion, current basal rate, basal rate profile, basal rate history for data management of patients using insulin pumps

Publicações

Histórico de despachos e eventos da marca no USPTO.

53 publicações encontradas

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/05/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

15/09/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

22/04/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

15/09/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

30/06/2020

PUBO

PUBLISHED FOR OPPOSITION

30/06/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/06/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/05/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

23/04/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/04/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/04/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

26/10/2019

GNRT

NON-FINAL ACTION E-MAILED

26/10/2019

CNRT

NON-FINAL ACTION WRITTEN

26/10/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/10/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/10/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/10/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

30/04/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/04/2019

GNRT

NON-FINAL ACTION E-MAILED

16/04/2019

CNRT

NON-FINAL ACTION WRITTEN

16/04/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

25/03/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

22/09/2018

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

22/03/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/02/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

22/09/2017

GNSL

LETTER OF SUSPENSION E-MAILED

22/09/2017

CNSL

SUSPENSION LETTER WRITTEN

22/09/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/09/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/09/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

20/09/2017

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

17/07/2017

GNSI

INQUIRY TO SUSPENSION E-MAILED

17/07/2017

CNSI

SUSPENSION INQUIRY WRITTEN

17/07/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

16/01/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

14/07/2016

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/05/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/05/2016

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

14/01/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

14/07/2015

GNSL

LETTER OF SUSPENSION E-MAILED

14/07/2015

CNSL

SUSPENSION LETTER WRITTEN

14/07/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/06/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/06/2015

ALIE

ASSIGNED TO LIE

15/06/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/06/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/12/2014

GNRT

NON-FINAL ACTION E-MAILED

10/12/2014

CNRT

NON-FINAL ACTION WRITTEN

10/12/2014

DOCK

ASSIGNED TO EXAMINER

01/12/2014

MPMK

NOTICE OF PSEUDO MARK E-MAILED

23/08/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

22/08/2014

NWAP

NEW APPLICATION ENTERED

18/08/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MYLIFE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.